Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BLX-028914 in Seasonal Allergic Rhinitis
NCT00758446Phase 2Completed
- Sponsor
- Dart NeuroScience LLC
- Start
- Sep 2008
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of HT-0712 in seasonal allergic rhinitis (SAR) (3 arms), sponsored by Dart NeuroScience LLC. Primary endpoint: Total Nasal Symptom Score. Started Sep 2008; status: completed.
02
Drugs
HT-0712
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00758446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00758446.